Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The primary objective of this study is to compare absorption of vitamin K2 (menaquinone-7) after intake of three different vitamin K2 supplements.
Several manufacturers are producing vitamin K2 raw material in different forms, namely oil and powder. To ensure bioequivalence of different vitamin K2 sources, the investigators are interested to compare the bioavailability of three different vitamin K2 formulations that are already commercially available. Two different oils and one powder product will be compared in this randomized cross-over trial. The investigators hypothesize that different vitamin K2 sources give no differences in bioavailability of vitamin K2.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Gnosis P-1000 capsules | Active Comparator | MK-7 capsules containing 75 µg of MK-7 (source: Gnosis, Italy). |
|
| Gnosis M1500 capsules | Active Comparator | MK-7 capsules containing 75 µg of MK-7 (source Gnosis, Italy). |
|
| MenaQ7 M-1500 capsules | Active Comparator | MK-7 capsules containing 75 µg of MK-7 (source: Nattopharma, Norway) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| MenaQ7 M-1500 capsules | Dietary Supplement | The study participants will receive three different types of capsules as a single dose (75 μg of MK-7/day):
Every two weeks, participants switch to another type of capsule; the washout period will therefore be two weeks. |
| Measure | Description | Time Frame |
|---|---|---|
| MK-7 absorption profiles | The purpose of this study is to compare the MK-7 absorption profiles after intake of three different vitamin K2 (MK-7) products that are already on the market. The main study parameter is therefore the calculated AUC value from the individual MK-7 absorption profiles. | 9 weeks |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Cees Vermeer, PhD | VitaK BV Maastricht University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| VitaK BV / Maastricht University Medical Center | Maastricht | Netherlands |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Gnosis P-1000 capsules | Dietary Supplement | The study participants will receive three different types of capsules as a single dose (75 μg of MK-7/day):
|
|
| Gnosis M-1500 capsules | Dietary Supplement | The study participants will receive three different types of capsules as a single dose (75 μg of MK-7/day):
Every two weeks, participants switch to another type of capsule; the washout period will therefore be two weeks. |
|